3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
47
Recurrence
9
Sarcoma, Kaposi
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
Plasmacytoma
1
Plasmablastic Lymphoma
1
Multi-centric Castleman's Disease
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Epstein-Barr Virus Infections
1
Interventions
Azacitidine
12
Cyclophosphamide
10
venetoclax
8
fludarabine phosphate
7
fludarabine
7
Whole-Body Irradiation
7
Biopsy
7
Specimen Handling
6
Mycophenolic Acid
6
Injections
6
Decitabine
6
Tacrolimus
5
Cytarabine
5
Busulfan
5
decitabine and cedazuridine drug combination
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Cyclosporine
4
cedazuridine
3
X-Rays
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
olutasidenib
2
Vorinostat
2
Sirolimus
2
Rituximab
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Lenalidomide
2
Idarubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
pomalidomide
×
90 days
×
Clear all
No trials found.